PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
Nathan R. Fons(Yale University), Ranjit S. Bindra(Yale University), Ranjini K. Sundaram(Yale University), Mark S. Schmidt(University of Iowa), Chris Jones(North Carolina State University), Aravind Kalathil(Yale University), Michael E. Berens(Translational Genomics Research Institute), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Charles Brenner(City Of Hope National Medical Center), Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Ryan L. McLean(Yale University), Javad Nazarian(University Children's Hospital Zurich), Sen Peng(Translational Genomics Research Institute), G. Breuer(Yale Cancer Center)
Cited by 75
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869